+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Uveitis Drugs Market 2021-2025- Product Image

Global Uveitis Drugs Market 2021-2025

  • ID: 5305724
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • AbbVie Inc.
  • Alimera Sciences Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Cadila Healthcare Ltd.
  • Johnson & Johnson
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Uveitis Drugs Market 2021-2025

The publisher has been monitoring the uveitis drugs market and it is poised to grow by $ 248.42 mn during 2021-2025 progressing at a CAGR of 6% during the forecast period. The report on uveitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of eye disorders and associated risk factors of uveitis and strong pipeline. In addition, high prevalence of eye disorders and associated risk factors of uveitis is anticipated to boost the growth of the market as well.

The uveitis drugs market analysis includes product segment and geographical landscapes.

The uveitis drugs market is segmented as below:

By Product
  • Small molecules
  • Biologics
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the recent advances in diagnostics of eye disorders as one of the prime reasons driving the uveitis drugs market growth during the next few years.

The report on uveitis drugs market covers the following areas:
  • Uveitis drugs market sizing
  • Uveitis drugs market forecast
  • Uveitis drugs market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading uveitis drugs market vendors that include AbbVie Inc., Alimera Sciences Inc., Amgen Inc., Biogen Inc., Cadila Healthcare Ltd., EyePoint Pharmaceuticals Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.. Also, the uveitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Alimera Sciences Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Cadila Healthcare Ltd.
  • Johnson & Johnson
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Small molecules - Market size and forecast 2020-2025
  • Biologics - Market size and forecast 2020-2025
  • Market opportunity by Product
Customer landscape
  • Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Alimera Sciences Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Cadila Healthcare Ltd.
  • EyePoint Pharmaceuticals Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Small molecules - Market size and forecast 2020-2025 ($ million)
  • Small molecules - Year-over-year growth 2020-2025 (%)
  • Biologics - Market size and forecast 2020-2025 ($ million)
  • Biologics - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Alimera Sciences Inc. - Overview
  • Alimera Sciences Inc. - Product and service
  • Alimera Sciences Inc. - Key offerings
  • Alimera Sciences Inc. - Key customers
  • Alimera Sciences Inc. - Segment focus
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Biogen Inc. - Overview
  • Biogen Inc. - Business segments
  • Biogen Inc. - Key offerings
  • Biogen Inc. - Key customers
  • Biogen Inc. - Segment focus
  • Cadila Healthcare Ltd. - Overview
  • Cadila Healthcare Ltd. - Product and service
  • Cadila Healthcare Ltd. - Key offerings
  • Cadila Healthcare Ltd. - Key customers
  • Cadila Healthcare Ltd. - Segment focus
  • EyePoint Pharmaceuticals Inc. - Overview
  • EyePoint Pharmaceuticals Inc. - Product and service
  • EyePoint Pharmaceuticals Inc. - Key offerings
  • EyePoint Pharmaceuticals Inc. - Key customers
  • EyePoint Pharmaceuticals Inc. - Segment focus
  • Johnson & Johnson - Overview
  • Johnson & Johnson - Business segments
  • Johnson & Johnson - Key offerings
  • Johnson & Johnson - Key customers
  • Johnson & Johnson - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Regeneron Pharmaceuticals Inc. - Overview
  • Regeneron Pharmaceuticals Inc. - Product and service
  • Regeneron Pharmaceuticals Inc. - Key offerings
  • Regeneron Pharmaceuticals Inc. - Key customers
  • Regeneron Pharmaceuticals Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Alimera Sciences Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Cadila Healthcare Ltd.
  • Johnson & Johnson
The publisher recognizes the following companies as the key players in the global uveitis drugs market: AbbVie Inc., Alimera Sciences Inc., Amgen Inc., Biogen Inc., Cadila Healthcare Ltd., EyePoint Pharmaceuticals Inc., Johnson & Johnson, Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is recent advances in diagnostics of eye disorders.'

According to the report, one of the major drivers for this market is the high prevalence of eye disorders and associated risk factors of uveitis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Alimera Sciences Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Cadila Healthcare Ltd.
  • EyePoint Pharmaceuticals Inc.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll